◆英語タイトル:Pure Bioscience Inc (PURE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013191
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月28日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Pure Bioscience Inc (Pure) is involved in the development and commercialization of proprietary antimicrobial products. It develops and markets proprietary antimicrobial products principally in the food safety field providing solutions to the health and environmental challenges of pathogen and hygienic control. The company’s technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate (SDC), a broad-spectrum, non-toxic antimicrobial agent that provides 24-hour residual protection and formulates well with other compounds. It also manufactures and sells SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products. Pure is headquartered in El Cajon, California, the US.
Pure Bioscience Inc (PURE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pure Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pure Bioscience Inc, Medical Devices Deals, 2011 to YTD 2017 9
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Pure Bioscience Enters Into Co-Marketing Agreement With Intercon Chemical 11
Licensing Agreements 12
Pure Bioscience Enters into Licensing Agreement with Research Instruments 12
Equity Offering 13
Pure Bioscience Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 13
Pure Bioscience Raises USD6 Million in Private Placement of Shares 14
Pure Bioscience Completes Public Offering Of Shares For US$5 Million 15
Pure Bioscience Completes Private Placement Of Shares For US$1 Million 17
Pure Bioscience Completes Private Placement Of Shares For US$4.3 Million 18
Pure Bioscience Inc – Key Competitors 19
Pure Bioscience Inc – Key Employees 20
Pure Bioscience Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Financial Announcements 22
Mar 02, 2017: PURE Bioscience Reports Improved 2017 Fiscal Second Quarter and Six-Month Financial Results 22
Dec 14, 2016: PURE Bioscience Reports Q1 2017 Financial Results 23
Oct 27, 2016: PURE Bioscience Reports Fiscal 2016 Year-End Financial Results 24
Jun 09, 2016: PURE Bioscience Reports 2016 Fiscal Third Quarter and Nine-Month Financial Results 25
Mar 09, 2016: PURE Bioscience Reports 2016 Fiscal Second Quarter and Six-Month Financial Results 27
Corporate Communications 28
Nov 02, 2017: PURE Bioscience Expands Board of Directors with Appointment of Elisabeth Hagen, M.D., Food Safety Consultant 28
Legal and Regulatory 29
Apr 27, 2017: PURE Bioscience Receives USDA Permission Letter and FDA FCN Acknowledgement Letter 29
Apr 07, 2016: PURE Bioscience Receives USDA Permission Letter to Begin In-Plant Poultry Processing Trial Using SDC-Based PURE Control Antimicrobial 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31
List of Tables
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pure Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pure Bioscience Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Pure Bioscience Inc, Medical Devices Deals, 2011 to YTD 2017 9
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pure Bioscience Enters Into Co-Marketing Agreement With Intercon Chemical 11
Pure Bioscience Enters into Licensing Agreement with Research Instruments 12
Pure Bioscience Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 13
Pure Bioscience Raises USD6 Million in Private Placement of Shares 14
Pure Bioscience Completes Public Offering Of Shares For US$5 Million 15
Pure Bioscience Completes Private Placement Of Shares For US$1 Million 17
Pure Bioscience Completes Private Placement Of Shares For US$4.3 Million 18
Pure Bioscience Inc, Key Competitors 19
Pure Bioscience Inc, Key Employees 20